Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2015-07-30 08:55 | English | 380.9 KB | |||
| 2015-07-30 08:15 |
Pharming Reports on Financial Results First Half Year 2015
|
English | 385.6 KB | ||
| 2015-07-21 08:20 |
HAEi Global Access Program for RUCONEST® Now Live
|
English | 128.6 KB | ||
| 2015-07-20 13:00 |
PHARMING ANNOUNCES US$17 MILLION (€15.6 MILLION) STRAIGHT DEBT FINANCING
|
English | 143.7 KB | ||
| 2015-06-01 08:46 |
Pharming Announces Interim Results From the Ongoing Phase II Pediatric Clinical…
|
English | 42.8 KB | ||
| 2015-05-26 08:08 |
Pharming and Cytobioteck Announce Distribution Agreement for Ruconest
|
English | 136.5 KB | ||
| 2015-05-18 08:38 |
Pharming and Clinigen Group Initiate "HAEi GAP" Global Access Program for RUCON…
|
English | 65.0 KB | ||
| 2015-05-01 08:06 |
Pharming Reports on Annual General Meeting of Shareholders
|
English | 76.5 KB | ||
| 2015-04-30 10:07 | English | 343.2 KB | |||
| 2015-04-30 07:23 |
Pharming Reports on Financial Results for Q1 2015
|
English | 343.2 KB | ||
| 2015-03-19 07:19 |
Pharming Nominates Paul Sekhri and Jan Egberts as Members of its Board of Super…
|
English | 156.0 KB | ||
| 2015-03-19 07:14 | English | 1.3 MB | |||
| 2015-03-05 07:15 |
Pharming Reports on Preliminary Financial Results 2014
|
English | 302.9 KB | ||
| 2015-02-18 07:20 |
Pharming Appoints Dr. Perry Calias as Chief Scientific Officer
|
English | 103.8 KB | ||
| 2015-01-08 07:26 |
Pharming and Salix Announce First Patient Treated in Clinical Study of Ruconest…
|
English | 126.1 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
